JP2001516719A5 - - Google Patents

Download PDF

Info

Publication number
JP2001516719A5
JP2001516719A5 JP2000511500A JP2000511500A JP2001516719A5 JP 2001516719 A5 JP2001516719 A5 JP 2001516719A5 JP 2000511500 A JP2000511500 A JP 2000511500A JP 2000511500 A JP2000511500 A JP 2000511500A JP 2001516719 A5 JP2001516719 A5 JP 2001516719A5
Authority
JP
Japan
Prior art keywords
methylpiperazin
tetrahydro
naphthyl
component
morpholinobenzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000511500A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516719A (ja
Filing date
Publication date
Priority claimed from SE9703376A external-priority patent/SE9703376D0/xx
Application filed filed Critical
Publication of JP2001516719A publication Critical patent/JP2001516719A/ja
Publication of JP2001516719A5 publication Critical patent/JP2001516719A5/ja
Pending legal-status Critical Current

Links

JP2000511500A 1997-09-18 1998-09-09 モノアミンオキシダーゼ阻害剤およびh5−HT1Bアンタゴニストまたは部分的アゴニストの組み合わせ Pending JP2001516719A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
SE9703376-5 1997-09-18
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (2)

Publication Number Publication Date
JP2001516719A JP2001516719A (ja) 2001-10-02
JP2001516719A5 true JP2001516719A5 (https=) 2006-01-05

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000511500A Pending JP2001516719A (ja) 1997-09-18 1998-09-09 モノアミンオキシダーゼ阻害剤およびh5−HT1Bアンタゴニストまたは部分的アゴニストの組み合わせ

Country Status (27)

Country Link
US (1) US6159970A (https=)
EP (1) EP1014986B1 (https=)
JP (1) JP2001516719A (https=)
KR (2) KR20010024087A (https=)
CN (1) CN1278727A (https=)
AR (1) AR013503A1 (https=)
AT (1) ATE270889T1 (https=)
AU (1) AU752719B2 (https=)
BR (1) BR9812236A (https=)
CA (1) CA2302204A1 (https=)
DE (1) DE69825062T2 (https=)
DK (1) DK1014986T3 (https=)
EE (1) EE200000146A (https=)
ES (1) ES2222603T3 (https=)
HU (1) HUP0100621A2 (https=)
ID (1) ID25789A (https=)
IL (1) IL134775A0 (https=)
IS (1) IS5401A (https=)
MX (1) MXPA00002616A (https=)
NO (1) NO20001400L (https=)
PL (1) PL339368A1 (https=)
PT (1) PT1014986E (https=)
SE (1) SE9703376D0 (https=)
SK (1) SK2832000A3 (https=)
TR (1) TR200000725T2 (https=)
WO (1) WO1999013878A1 (https=)
ZA (1) ZA987804B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
ES2323451T7 (es) * 2001-07-20 2011-08-01 Psychogenics Inc. Tratamiento para el trastorno de hiperactividad con deficit de atencion.
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP2009533325A (ja) * 2006-03-17 2009-09-17 アストラゼネカ・アクチエボラーグ 5−ht6調節剤としての新規なテトラリン
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
NZ602312A (en) 2010-03-10 2014-02-28 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用
IL321485A (en) * 2022-12-14 2025-08-01 Luminous Mind Inc Treatment of psychological symptoms affecting other medical conditions (PFAOMC)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT533268E (pt) * 1991-09-18 2002-02-28 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Similar Documents

Publication Publication Date Title
JP2001516718A5 (https=)
JP2001516719A5 (https=)
RU2214824C2 (ru) Комбинация ингибитора обратного захвата 5-ht и антагониста или частичного агониста h5-ht1b
RU2000109563A (ru) Комбинация обратного поглощения 5-нт селективного антагониста или частичного агониста н5-нт1b
JP2008538741A (ja) 鬱病の治療用及び/又は予防用の医薬組成物
EP3219308A1 (en) Melt-extruded solid dispersions containing an apoptosis-inducing agent
JP2008531714A (ja) 不安障害の治療用及び/又は予防用の医薬組成物
JP2004538259A5 (https=)
JP2008531715A (ja) 統合失調症及び関連疾患の治療用及び/又は予防用の医薬組成物
JP2005501120A5 (https=)
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
TW200916103A (en) Therapeutic compositions and methods
RU2005102098A (ru) Амидное производное
JP2018512403A5 (https=)
TW201912153A (zh) 用於治療b型肝炎的化合物、醫藥組合物及方法
US6054455A (en) Method for treating or preventing chronic nonbacterial prostatitis and prostatodynia
SE9703376D0 (sv) A new combination
JP2020526494A (ja) Nk−1アンタゴニスト組成物およびうつ病の処置における使用法
JP2001516717A5 (https=)
US20070015763A1 (en) Treatment of psychosis associated with parkinson's disease and subcortical dementias using a combination of an atypical antipsychotic with a dopamine agonist
RU2215528C2 (ru) Комбинация селективного антагониста 5-нт1a и селективного антагониста или частичного агониста н5-нт1b
RU2000109558A (ru) Комбинация селективного антагониста 5-нт1a и селективного антагониста или частичного агониста н5-нт1b
JP2021503457A5 (https=)
JP2023507816A5 (https=)
RU2007101522A (ru) Диарилметилпиперазиновые производные, их получение и применение